| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/0333102417694881 |
| P8608 | Fatcat ID | release_kk6c4fwy4bgbxezwbmq3x57aha |
| P698 | PubMed publication ID | 28952322 |
| P50 | author | Md Asiful Islam | Q57885931 |
| Siew Hua Gan | Q42700244 | ||
| Cinzia Cavestro | Q46871374 | ||
| P2093 | author name string | Fahmida Alam | |
| Kah Keng Wong | |||
| P2860 | cites work | Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients | Q28212959 |
| International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 | ||
| The International Classification of Headache Disorders, 3rd edition (beta version) | Q29392338 | ||
| Brain abnormalities in newly diagnosed neuropsychiatric lupus: systematic MRI approach and correlation with clinical and laboratory data in a large multicenter cohort | Q30873630 | ||
| The blood-brain barrier in systemic lupus erythematosus | Q30887274 | ||
| Postural tachycardia syndrome (POTS) and other autonomic disorders in antiphospholipid (Hughes) syndrome (APS). | Q33163886 | ||
| Asymptomatic intracardiac thrombi and primary antiphospholipid syndrome | Q33331236 | ||
| Lupus-specific autoantibodies in concomitant human immunodeficiency virus and systemic lupus erythematosus: case report and literature review | Q33337727 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus | Q33358014 | ||
| Long-term follow-up in 128 patients with primary antiphospholipid syndrome: do they develop lupus? | Q33367182 | ||
| Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association? | Q33370780 | ||
| Antiphospholipid syndrome in Latin American patients: clinical and immunologic characteristics and comparison with European patients | Q33375598 | ||
| Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort | Q33384874 | ||
| Cerebrovascular ischemic events with high positive anticardiolipin antibodies | Q33504162 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| Prothrombotic states in migraine. | Q51025787 | ||
| Neuropsychiatric manifestations and antiphospholipid antibodies in pediatric onset lupus: 14 years of experience from a tertiary center of North India. | Q51648992 | ||
| Idiopathic intracranial hypertension as a significant cause of intractable headache in patients with systemic lupus erythematosus: a 15-year experience. | Q53389103 | ||
| Temporal Arteritis | Q56484960 | ||
| Migraineurs show a high prevalence of antiphospholipid antibodies | Q57272263 | ||
| Migraine and Antiphospholipid Antibodies: No Association Found in Migraine-Discordant Monozygotic Twins | Q58210773 | ||
| Peripheral injections of Freund's adjuvant in mice provoke leakage of serum proteins through the blood-brain barrier without inducing reactive gliosis | Q33865528 | ||
| Traumatic intracerebral venous thrombosis associated with an abnormal golf swing | Q34001185 | ||
| Headache and systemic lupus erythematosus | Q34288843 | ||
| Prevalence and factors associated with headache in patients with systemic lupus erythematosus | Q34371567 | ||
| Pathophysiology of migraine | Q34494322 | ||
| Headache, Raynaud's syndrome and serotonin receptor agonists in systemic lupus erythematosus | Q34583641 | ||
| Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus | Q35185887 | ||
| Pattern of MRI brain in neuro-psychiatric SLE. Effect of anti-phospholipid antibodies: A study at a tertiary care teaching hospital | Q36270159 | ||
| Cellular elements of the blood-brain barrier | Q37621370 | ||
| Revisiting the molecular mechanism of neurological manifestations in antiphospholipid syndrome: beyond vascular damage | Q37704593 | ||
| Epidemiology of migraine and headache in children and adolescents | Q38108743 | ||
| A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus. | Q38615244 | ||
| Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome. | Q38753510 | ||
| Neuropsychiatric manifestations in a consecutive cohort of systemic lupus erythematosus; a single center study | Q38856432 | ||
| Pediatric antiphospholipid syndrome: clinical and immunologic features of 121 patients in an international registry. | Q40032766 | ||
| Systemic lupus erythematosus (SLE) in the eastern region of Saudi Arabia. A comparative study | Q40238380 | ||
| Rhupus; unusual presentations | Q40283710 | ||
| Vasculitis as a reason of chronic headache | Q40416998 | ||
| Autoimmune intrahepatic cholangiopathy associated with antiphospholipid antibody syndrome | Q40439145 | ||
| 'A stroke of luck': a case report of a right-sided cerebellar cerebrovascular accident in a young man. | Q40608601 | ||
| Kingella endocarditis and meningitis in a patient with SLE and associated antiphospholipid syndrome | Q40619110 | ||
| Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells | Q40997117 | ||
| Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus | Q41977234 | ||
| Catastrophic antiphospholipid syndrome presenting as bilateral central retinal artery occlusions | Q42021039 | ||
| Headache disorders are third cause of disability worldwide | Q42407201 | ||
| Antiphospholipid Antibodies in Migraine | Q43514382 | ||
| Intracranial venous thrombosis and pulmonary embolism with antiphospholipid syndrome in systemic lupus erythematosus | Q43725671 | ||
| Optic neuropathy in primary antiphospholipid syndrome in childhood | Q43749747 | ||
| Occurrence of factor V Leiden mutation (Arg506Gln) and anticardiolipin antibodies in migraine patients. | Q43971690 | ||
| Transient monocular blindness and antiphospholipid antibodies in systemic lupus erythematosus | Q44265237 | ||
| Migrainous phenomena in systemic lupus erythematosus | Q46847911 | ||
| Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement | Q48172708 | ||
| Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes | Q48245672 | ||
| Antiphospholipid antibodies bind to rat cerebellar granule cells: the role of N-methyl-D-aspartate receptors | Q48321209 | ||
| A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity? | Q48373517 | ||
| Prothrombotic risk factors in ischemic stroke and migraine in children | Q48497008 | ||
| Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics | Q48573564 | ||
| Uncommon cause of sinus thrombosis following closed mild head injury in a child | Q49213203 | ||
| Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. | Q50780156 | ||
| Factors and comorbidities associated with central nervous system involvement in systemic lupus erythematosus: a retrospective cross-sectional case-control study from a single center. | Q50785654 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 568-580 | |
| P577 | publication date | 2017-02-20 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Coexistence of antiphospholipid antibodies and cephalalgia | |
| P478 | volume | 38 |
Search more.